Display options
Cite
De Bruyne S, Steel E, Petrick M, et al. Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm. Clin Chem Lab Med. 2021;59(10):e392-e394doi: 10.1515/cclm-2020-1884.
De Bruyne, S., Steel, E., Petrick, M., Denys, B., Vandepoele, K., Van Roy, N., Degandt, S., Ghys, T., & Louagie, H. (2021). Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm. Clinical chemistry and laboratory medicine, 59(10), e392-e394. https://doi.org/10.1515/cclm-2020-1884
De Bruyne, Sander, et al. "Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm." Clinical chemistry and laboratory medicine vol. 59,10 (2021): e392-e394. doi: https://doi.org/10.1515/cclm-2020-1884
De Bruyne S, Steel E, Petrick M, Denys B, Vandepoele K, Van Roy N, Degandt S, Ghys T, Louagie H. Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm. Clin Chem Lab Med. 2021 May 10;59(10):e392-e394. doi: 10.1515/cclm-2020-1884. Print 2021 Sep 27. PMID: 33964201.
Copy Download .nbib Format: NLM
Share it on

Clin Chem Lab Med. 2021 May 10;59(10):e392-e394. doi: 10.1515/cclm-2020-1884. Print 2021 Sep 27.

Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm.

Clinical chemistry and laboratory medicine

Sander De Bruyne, Eva Steel, Marjan Petrick, Barbara Denys, Karl Vandepoele, Nadine Van Roy, Simon Degandt, Timothy Ghys, Henk Louagie

Affiliations

  1. Department of Laboratory Medicine, AZ Sint-Lucas, Ghent, Belgium.
  2. Department of Haematology, AZ Sint-Lucas, Ghent, Belgium.
  3. Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
  4. Department of Biomolecular Medicine, Ghent University Hospital, Ghent, Belgium.

PMID: 33964201 DOI: 10.1515/cclm-2020-1884

[No abstract available.]

Keywords: BCR-ABL1 ; JAK2 ; chronic myeloid leukemia; essential thrombocythemia; myeloproliferative neoplasm

References

  1. Grinfeld, J, Nangalia, J, Baxter, EJ, Wedge, DC, Angelopoulos, N, Cantrill, R, et al.. Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med 2018;379:1416–30. https://doi.org/10.1056/nejmoa1716614. - PubMed
  2. Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al.. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2017. - PubMed
  3. Lorenzo, M, Grille, S, Stevenazzi, M. Emergence of BCR-ABL1 chronic myeloid leukemia in a JAK2-V617F polycythemia vera. J Hematol 2020;9:23–9. https://doi.org/10.14740/jh591. - PubMed
  4. Martin-Cabrera, P, Haferlach, C, Kern, W, Schnittger, S, Haferlach, T. BCR-ABL1-positive and JAK2 V617F-positive clones in 23 patients with both aberrations reveal biologic and clinical importance. Br J Haematol 2017;176:135–9. https://doi.org/10.1111/bjh.13932. - PubMed
  5. Cerquozzi, S, Tefferi, A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J 2015;5:e366. https://doi.org/10.1038/bcj.2015.95. - PubMed
  6. Hassankrishnamurthy, S, Mody, MD, Kota, VK. A case of chronic myelogenous leukemia occurring in a patient treated for essential thrombocythemia. Am J Case Rep 2019;20:10–4. https://doi.org/10.12659/ajcr.911854. - PubMed
  7. Bader, G, Dreiling, B. Concurrent JAK2-positive myeloproliferative disorder and chronic myelogenous leukemia: a novel entity? A case report with review of the literature. J Investig Med High Impact Case Rep 2019;7:2324709619832322. https://doi.org/10.1177/2324709619832322. - PubMed
  8. Scott, LM, Campbell, PJ, Baxter, EJ, Todd, T, Stephens, P, Edkins, S, et al.. The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders. Blood 2005;106:2920–1. https://doi.org/10.1182/blood-2005-05-2087. - PubMed
  9. Pardini, S, Fozza, C, Contini, S, Rimini, E, Ottaviani, E, Amabile, M, et al.. A case of coexistence between JAK2V617F and BCR/ABL. Eur J Haematol 2008;81:75–6. https://doi.org/10.1111/j.1600-0609.2008.01063.x. - PubMed
  10. Curtin, NJ, Campbell, PJ, Green, AR. The Philadelphia translocation and pre-existing myeloproliferative disorders. Br J Haematol 2005;128:734–6. https://doi.org/10.1111/j.1365-2141.2005.05396.x. - PubMed

Publication Types